PURA - Puration Fast Tracks California Cannabis Cultivation Acquisition On Heels Recent Of Canadian Acquisition

Dallas, TX -- May 22, 2018 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today announced taking over the acquisition prospect previously under a letter of intent with North American Cannabis Holdings, Inc. (USOTC: USMJ). Earlier this year, USMJ announced a letter of intent to acquire Turning Point Cannabis Strategies to advance an entry into the California cannabis market. Since that time, USMJ changed its business development plans and is actively pursuing different opportunities that do not include the acquisition of a cannabis business in California. Puration has stepped in to pursue the opportunity with Turning Point Cannabis Strategies in an effort to repeat the type of transaction the Company recently accomplished in Canada. Two weeks ago the company announced the acquisition of Canadian Cannabis Farmers Co-Op to position Puration for the recreational marijuana market expected to be legalized nationwide in Canada this summer. The company followed up the acquisition with an online presentation on the company’s overall cannabis cultivation business operation and plans for the future.

For more information on Puration, visit http://www.aciconglomerated.com.

Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350